2959, 2926, 2868, 2853, 1711, 1670, 1622, 1595, 1467, 1456,
1406, 1384, 1362, 1336, 1241, 912, 740; C64H82N2O4 (943.36):
calcd. C 81.49, H 8.76, N 2.97, O 6.78%; found C 79.93, H 8.73,
N 2.85%.
NMR (500 MHz, C2DCl3): d~10.09 (d, 3J (H,H)~8 Hz,
2 H; H-6, H-12), 8.68 (s, 2 H; H-2, H-8), 8.58 (d, 3J
(H,H)~8 Hz, 2 H; H-5, H-11), 5.01 (m, 2 H; 2 CH-N), 2.55
(m, 4 H; 4 CHcyclohex), 1.91 (m, 4 H; 4 CHcyclohex), 1.74
(m, 6 H; 6 CHcyclohex), 1.45 (m, 22 H; 4 CHcyclohex, 6 CH3),
1.32 (m, 2 H; 2 CHcyclohex); 13C NMR (125 MHz, C2D2Cl4,
50 uC): d~164.02, 163.83, 138.19, 134.39, 133.89, 130.25, 127.79,
127.59, 127.27, 123.64, 122.64, 121.22, 109.29, 81.48, 54.48,
34.90, 30.72, 29.93, 29.48, 29.18, 29.90, 25.80; UV/Vis (CHCl3):
lmax (e)~552 (45680), 511 (27020), 476 (14960), 297 nm
(41310 l mol21 cm21); fluorescence emission (CHCl3, exc.:
552 nm): lem~571 nm; MS (8 kV, FD): m/z~715.2 (100%)
[Mz] (calcd. 714.34).
N,N’-Di(n-octyl)-1,7-di(pentadec-1-ynyl)perylene-3,4:9,10-
tetracarboxydiimide (14g). N,N’-Di(n-octyl)-1,7-dibromopery-
lene-3,4:9,10-tetracarboxydiimide (13b) (3 g, 3.8 mmol) and
pentadec-1-yne (3.2 g, 15.5 mmol) were reacted as described
for (14). The red product (14g) (3.5 g, 89%) was isolated.
Mp 152 uC; 1H NMR (500 MHz, CD2Cl2): d~9.33 (d, 3J
(H,H)~8 Hz, 2 H; H-6, H-12), 8.03 (s, 2 H; H-2, H-8), 7.85 (d, 3J
(H,H)~8 Hz, 2 H; H-5, H-11), 4.07 (m, 8 H; 2 CH2-N, 2 CH2M),
1.95–1.18 (m, 68 H; 34 CH2), 0.90 (m, 12 H; 4 CH3); 13C NMR
(125 MHz, CD2Cl2): d~163.02, 162.87, 138.03, 134.12, 132.93,
129.93, 129.13, 128.73, 128.52, 127.08, 127.01, 126.98, 126.63,
122.97, 122.58, 122.03, 121.72, 120.80, 120.53, 103.83, 83.03,
41.31, 41.08, 32.84, 32.41, 30.28, 30.25, 30.19, 30.13, 30.09, 29.95,
29.90, 29.83, 29.75, 28.83, 27.72, 23.21, 23.15, 20.77, 14.34, 14.28;
UV/Vis (CHCl3): lmax (e)~552 (46580), 511 (29130), 476 (15240),
297 nm (40980 l mol21 cm21); fluorescence emission (CHCl3,
exc.: 552 nm): lem~572 nm; MS (8 kV, FD): m/z~1026.7
(100%) [Mz], 2054.3 (70%) [M2z], 3081.4 (20%) [M3z] (calcd.
1027.7).
N,N’-Dicyclohexyl-1,7-di(oct-1-ynyl)perylene-3,4:9,10-tetra-
carboxydiimide
(14d). N,N’-Dicyclohexyl-1,7-dibromopery-
lene-3,4:9,10-tetracarboxydiimide (13a) (750 mg, 1 mmol) and
oct-1-yne (467 mg, 4 mmol) were reacted as described for (14)
to give the red product 14d (750 mg, 92%). Mp 221 uC; 1H
3
NMR (500 MHz, CD2Cl2): d~9.03 (d, J (H,H)~8 Hz, 2 H;
3
H-6, H-12), 7.85 (s, 2 H; H-2, H-8), 7.73 (d, J (H,H)~8 Hz,
2 H; H-5, H-11), 4.91 (m, 2 H; 2 N-CH), 2.58 (m, 6 H; 2 MCH2,
4 CHcyclohex), 2.00 (m, 8 H; 4 CHcyclohex, 2 CH2), 1.78 (m, 10 H;
6 CHcyclohex, 2 CH2), 1.48 (m, 14 H; 4 CH2 und 6 CHcyclohex),
1.00 (t, 3J (H,H)~7 Hz, 6 H; 2 CH3); 13C NMR (75 MHz,
C2D2Cl4): d~163.12, 162.91, 137.46, 133.03, 132.47, 129.45,
126.53, 126.39, 125.96, 122.65, 121.70, 120.11, 101.97, 81.95,
53.82, 31.15, 28.73, 28.04, 26.41, 22.42, 20.04, 13.99; UV/Vis
(CHCl3): lmax (e)~552 (46210), 511 (28900), 476 (15050),
297 nm (41320 l mol21 cm21); fluorescence emission (CHCl3,
exc.: 552 nm): lem~571 nm; MS (8 kV, FD): m/z~770.3
(100%) [Mz] (calcd. 770.41).
N,N’-Bis(2,6-diisopropylphenyl)-1,7-di(dodec-1-ynyl)perylene-
3,4:9,10-tetracarboxydiimide
(14h). N,N’-Bis(2,6-diisopropyl-
phenyl)-1,7-dibromoperylene-3,4:9,10-tetracarboxydiimide (13c)
(3 g, 3.46 mmol) and dodec-1-yne (1.72 g, 10.38 mmol)
were reacted as described for (14) to give the product (14h)
(3,1 g, 85%). Mp 191 uC; 1H NMR (500 MHz, CD2Cl2): d~10.25
(d, 3J (H,H)~8 Hz, 2 H; H-6, H-12), 8.84 (s, 2 H; H-2, H-8), 8.74
(d, 3J (H,H)~8 Hz, 2 H; H-5, H-11), 7.57 (t, 3J (H,H)~8 Hz, 2 H),
7.43 (d, 3J (H,H)~8 Hz, 4 H), 2.75 (septet, 3J (H,H)~7 Hz, 4 H;
4 CHisopropyl), 2.68 (t, 3J (H,H)~7.3 Hz, 4 H; 2 CH2M), 1.94 (m, 4 H;
2 CH2), 1.78 (m, 4 H; 2 CH2), 1.61–1.19 (m, 24 H; 12 CH2), 1.17 (d,
3J (H,H)~7 Hz, 12 H; 4 (CH3)isopropyl), 0.83 (t, 3J (H,H)~7 Hz, 6
H; 2 CH3); 13C NMR (125 MHz, CD2Cl2): d~164.21, 163.79,
146.31, 146.27, 142.37, 138.47, 136.93, 133.97, 131.40, 131.29,
130.80, 130.58, 129.71, 129.45, 128.47, 126.62, 125.72, 124.27,
124.21, 123.05, 122.39, 122.14, 121.62, 121.14, 103.30, 83.07, 31.99,
29.69, 29.64, 29.60, 29.48, 29.40, 29.37, 29.34, 28.60, 23.90, 23.82,
22.74, 20.58, 13.93; UV/Vis (CHCl3): lmax (e)~552 (46980),
511 (27790), 476 (14980), 297 nm (40329 l mol21 cm21); fluores-
cence emission (CHCl3, exc.: 552 nm): lem~572 nm; MS (8 kV,
FD): m/z~1039.2 (100%) [Mz] (calcd. 1038.63); C72H82N2O4
(1069.52): calcd. C 83.10, H 8.29, N 2.62, O 5.98%; found C 82.79, H
8.22, N 2.56%.
N,N’-Dicyclohexyl-1,7-di(pentadec-1-ynyl)perylene-3,4:9,10-
tetracarboxydiimide (14e). N,N’-Dicyclohexyl-1,7-dibromopery-
lene-3,4:9,10-tetracarboxydiimide (13a) (1 g, 1.4 mmol) and
pentadecyne (880 mg, 4.23 mmol) were reacted as described for
(14) and the red product (14e) (1.1 g, 81%) was isolated. Mp
164 uC; 1H NMR (300 MHz, CD2Cl2): d~9.01 (d, 3J
(H,H)~8 Hz, 2 H; H-6, H-12), 7.81 (s, 2 H; H-2, H-8), 7.70 (d,
3J (H,H)~8 Hz, 2 H; H-5, H-11), 4.93–4.78 (m, 2 H; 2 CH-N),
2.56–2.39 (m, 8 H; 2 CH2M,4 CHcyclohex), 1.98–1.20 (m, 60 H; 22
3
CH2, 16 CHcyclohex), 0.81 (t, J (H,H)~7 Hz, 6 H; 2 CH3); 13C
NMR (75 MHz, C2D2Cl4): d~163.25, 163.05, 137.60, 133.32,
132.82, 129.67, 126.71, 126.25, 122.80, 121.86, 120.35, 101.81,
82.00, 53.84, 31.71, 29.52, 29.48, 29.43, 29.16, 29.06, 29.04, 28.92,
28.09, 26.41, 22.51, 20.06, 14.02; UV/Vis (CHCl3): lmax (e)~552
(47320), 511 (27990), 476 (15030), 297 nm (41870 l mol21 cm21);
fluorescence emission (CHCl3, exc.: 552 nm): lem~571 nm; MS
(8 kV, FD): m/z~966.3 (100%) [Mz] (calcd. 966.63).
N,N’-Dicyclohexyl-1,7-bis(2-phenylethynyl)perylene-3,4:9,10-
tetracarboxydiimide (14i). N,N’-Dicyclohexyl-1,7-dibromoper-
ylene-3,4:9,10-tetracarboxydiimide (13a) (500 mg, 0.7 mmol)
and phenylethyne (300 mg, 2.94 mmol) were reacted as described
for (14) to yield the red product (14i) (460 mg, 87%). Mp 165 uC;
1H NMR (500 MHz, CHCl3): d~10.08 (d, 3J (H,H)~8 Hz, 2 H;
H-6, H-12), 8.84 (s, 2 H; H-2, H-8), 8.69 (d, 3J (H,H)~8 Hz, 2 H;
H-5, H-11), 7.64 (m, 4 H; 4 H-Ph), 7.46 (m, 6 H; 6 H-Ph), 5.04
(m, 2 H; 2 N-CH), 2.56 (m, 4 H; 4 CHcyclohex), 1.91 (m, 4 H; 4
CHcyclohex), 1.76 (m, 6 H; 6 CHcyclohex), 1.45 (m, 4 H; 4 CHcyclohex),
1.35 (m, 2 H; 2 CHcyclohex); UV/Vis (CHCl3): lmax (e)~573
(38630), 531 (24850), 494 nm (10750 l mol21 cm21); fluorescence
emission (CHCl3, exc.: 572 nm): lem~590 nm; MS (8 kV, FD):
m/z~754.5 (100%) [Mz] (calcd. 754.28).
N,N’-Di(n-octyl)-1,7-di(dodec-1-ynyl)perylene-3,4:9,10-tetra-
carboxydiimide (14f). N,N’-Di(n-octyl)-1,7-dibromoperylene-
3,4:9,10-tetracarboxydiimide (13b) (2.5 g, 3.2 mmol) and
dodec-1-yne (2.12 g, 12.8 mmol) were reacted as described
for (14) to yield the red product (14f) (2.74 g, 91%). Mp 168 uC;
3
1H NMR (500 MHz, CD2Cl2): d~9.56 (d, J (H,H)~8 Hz, 2
H; H-6, H-12), 8.21 (s, 2 H; H-2, H-8), 8.07 (d, 3J (H,H)~8 Hz,
2 H; H-5, H-11), 4.09 (m, 8 H; 2 CH2-N, 2 CH2M), 1.1 (m, 56 H;
28 CH2), 0.91 (m, 12 H; 4 CH3); 13C NMR (125 MHz, CD2Cl2):
d~162.92, 162.71, 137.74, 133.74, 132.72, 129.62,128.97,
128.32, 128.15, 126.88, 126.81, 126.68, 126.29, 122.72, 122.25,
121.73, 121.37, 120.47, 120.26, 103.12, 82.63, 41.10, 40.86,
32.39, 32.32, 30.26, 30.21, 30.17, 30.12, 30.09, 29.91, 29.81,
29.73, 28.79, 27.66, 23.17, 23.12, 20.73, 14.33, 14.29; UV/Vis
(CHCl3): lmax (e)~552 (47030), 511 (29640), 476 (15680),
297 nm (42420 l mol21 cm21); fluorescence emission (CHCl3,
exc.: 552 nm): lem~571 nm; MS (8 kV, FD): m/z~942.4
(100%) [Mz] (calcd. 942.63); IR (KBr): (cm21)~3028, 3022,
Synthesis of N,N’-dialkyl-5,11-dialkylcoronene-2,3:8,9-
tetracarboxydiimides (9) (Scheme 3)
N,N’-Dialkyl-1,7-dialkynylperylene-3,4:9,10-tetracarboxydiimide
(14) (1 mmol) were dissolved in m-xylene (or toluene) (400 ml).
The solution was deoxygenated by bubbling with argon. DBU
1796
J. Mater. Chem., 2001, 11, 1789–1799